Patients undergoing hip replacement may be at lower risk of infection with better optimisation before surgery and certain types of operation27 July 2018Researchers from the Musculoskeletal Research Unit at the University of Bristol have identified the most important risk factors for developing severe infection after hip replacement. Patients who are under 60 years of age, males, those with chronic pulmonary disease, diabetes and a higher body mass index are at increased risk of having the joint replacement redone (known as revision) due to infection. The research also showed that some patients are at risk of early infection whilst others are more prone to late infection after hip replacement.
Why do some wounds fail to heal?19 July 2018Non-healing wounds such as pressure sores and diabetic ulcers are a growing health problem, and we still don’t know enough about how and why wound repair can fail. Thanks to an Elizabeth Blackwell Institute (EBI) Early Career Fellowship award, pharmacologist Dr Jenna Cash has set up her own lab to examine wound repair more closely and inform novel therapies for chronic wounds.
Bristol thinking globally for health18 July 2018Rachael Gooberman-Hill, Director of Elizabeth Blackwell Institute for Health Research, University of Bristol, describes the Institute's innovative approach to global health challenges. This blog is part of the Bristol Firsts series, celebrating Bristol-based innovations in the NHS’s 70th year.
Bristol researchers to benchmark medicine use across UK beef farms14 June 2018Researchers at the University of Bristol are to quantify and compare farm animal medicine use within and across UK beef operations. The project aims to help demonstrate and communicate the gains made to consumers, processors, retailers and policy makers.
Bristol Immunisation Group looks back at 2017-1814 June 2018Professor Adam Finn, Dr Julie Yates and Dr Marion Roderick, Directors of the Bristol Immunisation Group Health Integration Team (BIG HIT), give an update on the HIT's progress in 2017-18.
UK public shows strong preference for vaccines that prevent severe illness, particularly for children13 June 2018The UK public has a clear preference for funding vaccination programmes which protect young children against severe diseases, finds a new study that considered the public’s preferences on vaccines available on the NHS. The study suggests that the public’s preferences about which vaccines are made available on the NHS, particularly children, are not reflected by the current approach. The Meningitis Research Foundation (MRF)-funded study, led by University of Bristol researchers, is published today [13 June] in PLOS ONE.
Can a home WiFi router act as a medical sensing device?10 May 2018New research that could transform the future of healthcare will investigate whether it is possible to reuse WiFi radio waves as a medical radar system. The research, led by the University of Bristol, is part of a new £1.5 million grant awarded by the Engineering and Physical Sciences Research Council (EPSRC), Toshiba and Decawave to the OPERA project, a consortium including the universities of Bristol and Oxford; University College London and Coventry University.
Bristol Vet School at the forefront of combatting antimicrobial resistance28 April 2018Researchers from the Bristol Veterinary School at the University of Bristol are leading the way with farmers to combat and change antimicrobial (AM) use on farms. Antimicrobial resistance - or AMR - is a global threat, with an estimated 700,000 people dying from resistant infections every year.
Collaborative research to improve health and care18 April 2018Scientists are collaborating with NHS and public health staff to ensure that research evidence is used effectively to improve public health and patient outcomes. Professor Jenny Donovan, NIHR CLAHRC West Director, and Lara Edwards, NIHR CLAHRC West Manager, explain why collaboration is so important and offer some examples of the benefits it brings.
What is the best way to treat infected hip replacements?5 April 2018New research has found treating an infected hip replacement in a single stage procedure may be as effective or better than the widely used two-stage procedure. To date no well-designed study has compared these procedures head-to-head to decide if one is better or if they achieve the same results. Hip replacement is a very common operation that is effective at providing pain relief and improving mobility, however, infection can sometimes occur following joint replacement. The findings have wide implications for orthopaedic surgery, the NHS, and health systems worldwide.
Watch fat cells help heal a wound in a fly27 February 2018Fat body cells in Drosophila play a surprising role in sealing wounds and preventing infection, researchers at the University of Bristol report in the journal Developmental Cell.
Tackling antimicrobial resistance worldwide14 February 2018Antimicrobial resistance (AMR) is a serious and growing global health challenge. It occurs when microorganisms (such as bacteria, fungi and viruses) emerge that cannot be killed by normal doses of an antimicrobial drug (such as antibiotics and antivirals), making them less susceptible or resistant to antimicrobial agents. AMR can jeopardise the success of surgery and chemotherapy, and could have grave implications for the future of modern medicine. As such, it is an urgent global threat which requires a coordinated cross-government, academic and industry response. A GW4 research community has brought together leading AMR expertise across four universities to help tackle this issue.
Health Economics at Bristol updates11 January 2018The Health Economics at Bristol (HEB) team works closely with local and national policymakers and carries out methodological and applied research. Our three key research themes are the economics of health and care across the life course, efficiency and equity in decision-making, and methods for applied health economics.